Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4793-4802

  Chang, Minsun ^a,b   Peng, Kuan Wei ^a   Kastrati, Irida ^a   Overk, Cassia R ^a   Qin, Zhi Hui ^a   Yao, Ping ^a   Bolton, Judy L ^a   Thatcher, Gregory R J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYEQUILENIN; 4 METHOXYEQUILENIN; ANTIESTROGEN; AROMATIC HYDROCARBON RECEPTOR; CATECHOL; EQUILENIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; QUINONE DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN RESPONSIVE ELEMENT; GENE SILENCING; GENETIC TRANSCRIPTION; HORMONAL CARCINOGENESIS; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; LIGAND BINDING; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EQUILENIN; ESTROGEN RECEPTOR ALPHA; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LIGANDS; LUCIFERASES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; XENOBIOTICS;

EID: 34748925759     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1568     Document Type: Article

References (50)

1. Liehr JG 1990 Genotoxic effects of estrogens. Mutat Res 238:269-276
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick, ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
3. Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
4. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA 2007 The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674
5. Liehr JG 2001 Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7:273-281
6. Zhu BT, Conney AH 1998 Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27
7. Zhu BT, Liehr JG 1996 Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J Biol Chem 271:1357-1363
8. Zhang F, Chen Y, Pisha E, Shen L, Xiong Y, van Breemen RB, Bolton JL 1999 The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin- o-quinone. Chem Res Toxicol 12:204-213
9. Zhang F, Swanson SM, van Breemen RB, Liu X, Yang Y, Gu C, Bolton JL 2001 Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem Res Toxicol 14:1654-1659
10. Pisha E, Lui X, Constantinou AI, Bolton JL 2001 Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. Chem Res Toxicol 14:82-90
11. Bhavnani BR 1998 Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med 217:6-16
12. Liu X, Yao J, Pisha E, Yang Y, Hua Y, van Breemen RB, Bolton JL 2002 Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor α. Chem Res Toxicol 15:512-519
13. Spink DC, Zhang F, Hussain MM, Katz BH, Liu X, Hilker DR, Bolton JL 2001 Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells. Chem Res Toxicol 14:572-581
14. Yao J, Li Y, Chang M, Wu H, Yang X, Goodman JE, Liu X, Liu H, Mesecar AD, Van Breemen RB, Yager JD, Bolton JL 2003 Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol- O-methyltransferase. Chem Res Toxicol 16:668-675
15. Shen L, Pisha E, Huang Z, Pezzuto JM, Krol E, Alam Z, van Breemen RB, Bolton JL 1997 Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18:1093-1101
16. Rao PN, Somawardhana CW 1987 Synthesis of 2-methoxy and 4-methoxy equine estrogens. Steroids 49:419-432
17. Liu X, Zhang F, Liu H, Burdette JE, Li Y, Overk CR, Pisha E, Yao J, van Breemen RB, Swanson SM, Bolton JL 2003 Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin. Chem Res Toxicol 16:741-749
18. Jiang SY, Jordan VC 1992 Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84:580-591
19. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, Deng Y, Hedayat AS, Pauli GF, Farnsworth NR, van Breemen RB, Bolton JL 2005 Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem 53:6246-6253
20. Labarca C, Paigen K 1980 A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352
21. Catherino WH, Jordan VC 1995 Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett 92:39-47
22. Payne J, Jones C, Lakhani S, Kortenkamp A 2000 Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Sci Total Environ 248:51-62
23. Dawling S, Roodi N, Parl Fritz F 2003 Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res 63:3127-3132
24. Mugford CA, Mortillo M, Mico BA, Tarloff JB 1992 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats. Fundam Appl Toxicol 19:43-49
25. Dubey RK, Jackson EK, Gillespie DG, Rosselli M, Barchiesi F, Krust A, Keller H, Zacharia LC, Imthurn B 2005 Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab 90:247-255
26. Rochat B, Morsman JM, Murray GI, Figg WD, McLeod HL 2001 Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther 296:537-541
27. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S 2003 Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423:545-550
28. Santostefano M, Merchant M, Arellano L, Morrison V, Denison MS, Safe S 1993 α-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol Pharmacol 43:200-206
29. Gasiewicz TA, Rucci G 1991 α-Naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol Pharmacol 40:607-612
30. Brown AM, Jeltsch JM, Roberts M, Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344-6348
31. Levenson AS, Catherino WH, Jordan VC 1997 Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor. J Steroid Biochem Mol Biol 60:261-268
32. Seidel SD, Li V, Winter GM, Rogers WJ, Martinez EI, Denison MS 2000 Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists. Toxicol Sci 55:107-115
33. Lee JE, Safe S 2000 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol Sci 58:235-242
34. Mueck AO, Seeger H, Wallwiener D 2003 Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition. Climacteric 6:221-227
35. Van Aswegen CH, Purdy RH, Wittliff JL 1989 Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J Steroid Biochem 32:485-492
36. Martucci CP, Fishman J 1979 Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion. Endocrinology 105:1288-1292
37. Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Korzekwa KR, Fingerle J, Jackson EK 2000 Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun 278:27-33
38. Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR 2006 Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 147:4132-4150
39. Astroff B, Safe S 1988 Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8- trichlorodibenzofuran in the female rat. Toxicol Appl Pharmacol 95:435-443
40. Wormke M, Stoner M, Saville B, Safe S 2000 Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett 478:109-112
41. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, Savouret JF 1999 Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56:784-790
42. Amakura Y, Tsutsumi T, Nakamura M, Kitagawa H, Fujino J, Sasaki K, Toyoda M, Yoshida T, Maitani T 2003 Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol Pharm Bull 26:532-539
43. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491-502
44. Warner M, Gustafsson JA 2006 Nongenomic effects of estrogen: why all the uncertainty? Steroids 71:91-95
45. Pedram A, Razandi M, Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2009
46. Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA 1999 Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol 13:1912-1923
47. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
48. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G, Berstein L 2000 Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 95-112
49. Ball P, Stubenrauch G, Knuppen R 1977 Metabolism of 2-methoxy- and 4-methoxyoestrone in man in vivo. J Steroid Biochem 8:989-993
50. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS 2002 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β. Cancer Res 62:3691-3697